| History: From Bayer to Affymax | February 26, 2003 |
Gordon Ringold
|
Surromed |
Entrepreneurial Thought Leader Lectures |
| Views: 2988 |
|
| Video 5 of 14 from this talk |
- 01:59What is an Entrepreneur?
- 01:15Importance of Passion
- 01:37Being an Entrepreneur in Industry vs. Education: Team vs. Individual
- 02:46Types of Company in Biotech
- 03:20History: From Bayer to Affymax
- 02:58Biotech: Collaboration vs. Competition in Developing Affymax
- 01:56Pharmaceutical Companies: Challenges in Developing New Therapeutic Products
- 01:21Funding Challenges in Today's Market
- 01:21History of Maxygen
- 16:12History of Surromed
- 02:00Biggest Pharmaceutical Products in Industry Today
- 01:15How to Operate in a Downturn Economy
- 01:41When and How are Patents Important?
- 04:03Change the Business Plan in Response to a Changing Environment
Description
Ringold talks about the idea behind and the history of combinatorial chemistry to accelerate the process of drug discovery. He then talks about a technology that was invented for a different purpose but was eventually applied to the specific problem of broadly monitoring the expression of gene sequences giving birth to Affymetrix.
Comments 
Related Videos:
